Disseminated Salmonella typhimurium infection secondary to infliximab treatment

被引：18

作者：

Fu, A ^{[1
]}

Bertouch, JV ^{[1
]}

McNeil, HP ^{[1
]}

机构：

[1] Prince Wales Hosp, Sydney, NSW, Australia

来源：

ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期

关键词：

D O I：

10.1002/art.20639

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：3049 / 3049

页数：1

共 6 条

[1]

*CDCP, 1995, SALM SURV ANN TAB SU

[2]

Infections and anti-tumor necrosis factor α therapy [J].

Ellerin, T ;

Rubin, RH ;

Weinblatt, ME .

ARTHRITIS AND RHEUMATISM, 2003, 48 (11) :3013-3022

[3]

Effect of tumor necrosis factor α, interferon γ, and interleukin-4 on bacteria-enterocyte interactions [J].

Hess, DJ ;

Henry-Stanley, MJ ;

Erickson, EA ;

Wells, CL .

JOURNAL OF SURGICAL RESEARCH, 2002, 104 (02) :88-94

[4]

Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent [J].

Keane, J ;

Gershon, S ;

Wise, RP ;

Mirabile-Levens, E ;

Kasznica, J ;

Schwieterman, WD ;

Siegel, JN ;

Braun, MM .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (15) :1098-1104

[5]

Miller SI., 2000, PRINCIPLE PRACTICE I, V2, P2344

[6]

Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy -: Association with decreased interferon-γ production and toll-like receptor 4 expression [J].

Netea, MG ;

Radstake, T ;

Joosten, LA ;

van der Meer, JWM ;

Barrera, P ;

Kullberg, BJ .

ARTHRITIS AND RHEUMATISM, 2003, 48 (07) :1853-1857

← 1 →